Drug Shortage Report for LACTATED RINGER'S INJECTION, USP

Last updated on 2022-04-21 History
Report ID 158687
Drug Identification Number 00061085
Brand name LACTATED RINGER'S INJECTION, USP
Common or Proper name Lactated Ringer's Injection USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM LACTATE SODIUM CHLORIDE
Strength(s) 20MG 30MG 310MG 600MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1000ML
ATC code B05BB
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-04-14
Actual start date 2022-04-14
Estimated end date 2022-04-22
Actual end date 2022-04-20
Shortage status Resolved
Updated date 2022-04-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-04-21 English Compare
v5 2022-04-20 French Compare
v4 2022-04-20 English Compare
v3 2022-04-15 English Compare
v2 2022-04-12 French Compare
v1 2022-04-12 English Compare

Showing 1 to 6 of 6